It is well documented that TAGLN2 functions as a pivotal driver in various types of cancers, including meningioma [15], bladder cancer [33], colorectal cancer [34], esophageal squamous cell carcinoma [35] and so on. Here, TAGLN2 is linked to esophageal squamous cell carcinoma.